Tick-borne encephalitis (TBE) virus total antibody IVD, control - UK MHRA Medical Device Registration

Tick-borne encephalitis (TBE) virus total antibody IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 118578. The device is manufactured by Virion\Serion GmbH from Germany, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Launch Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Tick-borne encephalitis (TBE) virus total antibody IVD, control

MHRA Device ID: 118578•Ref: 118578

Device Type

In Vitro Diagnostic Device

Devices

Tick-borne encephalitis (TBE) virus total antibody IVD, control

Type

IVD General

Date Registered

Jul 12, 2021

Last Updated

Oct 13, 2022

Manufacturer Information

Name

Virion\Serion GmbH

Address

Friedrich-Bergius-Ring 19

Wurzburg, Germany

Created Date

Jul 12, 2021

Authorized Representative

Name

Launch Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Ash House Ash Road New Ash Green

Longfield, Kent, United Kingdom

Postcode: DA3 8JD

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Virion\Serion GmbH (10)

Other Products from Same Authorized Representative (10)

Tick-borne encephalitis (TBE) virus total antibody IVD, control - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Chikungunya virus immunoglobulin M (IgM) antibody IVD, control

Borrelia burgdorferi immunoglobulin G (IgG) antibody IVD, kit, enzyme immunoassay (EIA)

Coxiella burnetii immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

Chlamydia pneumoniae immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

Candida albicans immunoglobulin M (IgM) antibody IVD, control

Campylobacter jejuni antibody IVD, enzyme immunoassay (EIA)

Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody avidity index IVD, reagent

Coxsackie A/B virus immunoglobulin M (IgM) antibody IVD, enzyme immunoassay (EIA)

Chlamydia trachomatis immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

Aspergillus fumigatus immunoglobulin M (IgM) antibody IVD, control

Influenza A virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Measles virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Human herpesvirus 8 (HHV8) nucleic acid IVD, kit, nucleic acid technique (NAT)

Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT)

Legionella pneumophila nucleic acid IVD, kit, nucleic acid technique (NAT)

Listeria monocytogenes nucleic acid IVD, kit, nucleic acid technique (NAT)

Cryptosporidium species antigen IVD, kit, enzyme immunoassay (EIA)

Strongyloides stercoralis immunoglobulin G (IgG) antibody IVD, kit, enzyme immunoassay (EIA)

Human metapneumovirus (hMPV) nucleic acid IVD, kit, nucleic acid technique (NAT)

Multiple immunocompromised host infection-associated virus nucleic acid IVD, nucleic acid technique (NAT)